News
![A new approach to COVID-19 treatment](https://pharmaphorum.com/wp-content/uploads/2021/01/A-new-approach-to-COVID-19-treatment.jpg)
Mesoblast pummelled as Novartis exits COVID deal
Novartis as opted out of a collaboration with Mesoblast to develop its stem cell-based therapy remestemcel-L as a treatment for COVID-19, prompting a slump in the biotech's share price.